| Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors C Juhász, S Dwivedi, DO Kamson, SK Michelhaugh, S Mittal Molecular imaging 13 (6), 7290.2014. 00015, 2014 | 161 | 2014 |
| Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients A Trauninger, E Leél-Őssy, DO Kamson, L Pótó, M Aradi, F Kövér, M Imre, ... The journal of headache and pain 12, 97-103, 2011 | 101 | 2011 |
| Changes of migraine‐related white matter hyperintensities after 3 years: a longitudinal MRI study S Erdélyi‐Bótor, M Aradi, DO Kamson, N Kovács, G Perlaki, G Orsi, ... Headache: The Journal of Head and Face Pain 55 (1), 55-70, 2015 | 84 | 2015 |
| Quantitative MRI studies of chronic brain white matter hyperintensities in migraine patients M Aradi, A Schwarcz, G Perlaki, G Orsi, N Kovács, A Trauninger, ... Headache: The Journal of Head and Face Pain 53 (5), 752-763, 2013 | 77 | 2013 |
| State-of-the-art considerations in small cell lung cancer brain metastases RV Lukas, V Gondi, DO Kamson, P Kumthekar, R Salgia Oncotarget 8 (41), 71223, 2017 | 71 | 2017 |
| Differentiation of glioblastomas from metastatic brain tumors by tryptophan uptake and kinetic analysis: a positron emission tomographic study with magnetic resonance imaging … DO Kamson, S Mittal, A Buth, O Muzik, WJ Kupsky, NL Robinette, ... Molecular imaging 12 (5), 7290.2013. 00048, 2013 | 61 | 2013 |
| Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas E Bosnyák, DO Kamson, AR Guastella, K Varadarajan, NL Robinette, ... Neuro-oncology 17 (9), 1284-1292, 2015 | 52 | 2015 |
| Increased tryptophan uptake on PET has a strong independent prognostic value in patients with a previously treated high-grade glioma DO Kamson, S Mittal, NL Robinette, O Muzik, WJ Kupsky, GR Barger, ... Neuro-Oncology, 2014 | 49 | 2014 |
| In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2, 3-dioxygenase 1 IM Zitron, DO Kamson, S Kiousis, C Juhász, S Mittal Cancer Biology & Therapy 14 (4), 333-339, 2013 | 43 | 2013 |
| Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis DO Kamson, Z Illés, M Aradi, G Orsi, G Perlaki, E Leél-Őssy, ... Journal of Clinical Neuroscience 19 (5), 696-701, 2012 | 42 | 2012 |
| Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions S Erdélyi-Bótor, H Komáromy, DO Kamson, N Kovács, G Perlaki, G Orsi, ... Cephalalgia 37 (6), 571-580, 2017 | 41 | 2017 |
| Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates DO Kamson, C Juhász, A Buth, WJ Kupsky, GR Barger, PK Chakraborty, ... Journal of neuro-oncology 112, 121-132, 2013 | 37 | 2013 |
| Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium’s first workshop on CNS … SA Grossman, CG Romo, MA Rudek, J Supko, J Fisher, LB Nabors, ... Neuro-oncology 22 (10), 1422-1424, 2020 | 34 | 2020 |
| Prognostic molecular and imaging biomarkers in primary glioblastoma E Bosnyák, SK Michelhaugh, NV Klinger, DO Kamson, GR Barger, ... Clinical nuclear medicine 42 (5), 341-347, 2017 | 32 | 2017 |
| Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI E Bosnyák, DO Kamson, NL Robinette, GR Barger, S Mittal, C Juhász Journal of neuro-oncology 126, 317-325, 2016 | 30 | 2016 |
| The role of temozolomide in patients with newly diagnosed wild-type IDH, unmethylated MGMTp glioblastoma during the COVID-19 pandemic DO Kamson, SA Grossman JAMA oncology 7 (5), 675-676, 2021 | 29 | 2021 |
| Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas JW Jeong, C Juhász, S Mittal, E Bosnyák, DO Kamson, GR Barger, ... Cancer Imaging 15, 1-10, 2015 | 29 | 2015 |
| Severe relapse of vaccine-induced Guillain–Barre syndrome after treatment with Nivolumab C Yuen, D Kamson, B Soliven, C Kramer, F Goldenberg, K Rezania Journal of clinical neuromuscular disease 20 (4), 194-199, 2019 | 23 | 2019 |
| Glioblastoma resistance to chemotherapy: molecular mechanisms and innovative reversal strategies R Paulmurugan, TF Massoud Academic Press, 2021 | 21 | 2021 |
| Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis L Dresser, CA Yuen, A Wilmington, M Walker, TJ Vogel, RT Merrell, ... Scientific reports 10 (1), 17960, 2020 | 20 | 2020 |
Jeong-Won JeongProfessor of Pediatrics, Wayne State UniversityEmail verificata su med.wayne.edu
